You can’t start a company without a healthy dose of daring, and that’s certainly the case with NeuroBionics. The MIT-spinout thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy, and Parkinson’s disease.  Famed investor Steve Jurvetson of Future Ventures said that if everything goes […]

© 2024 TechCrunch. All rights reserved. For personal use only.